0001127602-21-025686.txt : 20210922 0001127602-21-025686.hdr.sgml : 20210922 20210922161541 ACCESSION NUMBER: 0001127602-21-025686 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210920 FILED AS OF DATE: 20210922 DATE AS OF CHANGE: 20210922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McKee Amy E CENTRAL INDEX KEY: 0001883764 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 211269801 MAIL ADDRESS: STREET 1: 4505 EMPEROR BLVD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-09-20 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001883764 McKee Amy E 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Non-Qualified Stock Option 15.02 2021-09-20 4 A 0 53333 0 A 2031-09-20 Common Stock 53333 53333 D Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan. The option vests 1/36 per month for a period of 36 months, beginning on October 20, 2021 /s/ Jessica Dickerson, by power of attorney 2021-09-22